Efficacy of Idarucizumab, Prothrombin Complex Concentrate (PCC) and Activated PCC to Reverse the Anticoagulatory Potential of Dabigatran in a Porcine Polytrauma Model

Critical Care - United Kingdom
doi 10.1186/cc14431
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Safety of 4-Factor Prothrombin Complex Concentrate (4f-Pcc) for Emergent Reversal of Factor Xa Inhibitors

Journal of Intensive Care
Critical CareIntensive Care Medicine
2018English

Use of 4-Factor Prothrombin Complex Concentrate in the Treatment of a Gastrointestinal Hemorrhage Complicated by Dabigatran

International Journal of Emergency Medicine
Emergency Medicine
2015English

Volume Replacement Strategies Do Not Impair the Binding of Dabigatran to Idarucizumab: Porcine Model of Hemodilution

PLoS ONE
Multidisciplinary
2019English

Prothrombin Complex Concentrate

Reactions Weekly
2016English

Prothrombin Complex Concentrate

Reactions Weekly
2017English

Prothrombin Complex Concentrate

Reactions Weekly
2017English

Prothrombin-Complex-Concentrate

Reactions Weekly
2017English

Prothrombin Complex Concentrate-Induced Disseminated Intravascular Coagulation Can Be Prevented by Coadministering Antithrombin in a Porcine Trauma Model

Anesthesiology
AnesthesiologyPain Medicine
2019English

Original Article Comparative Study of Prothrombin Complex Concentrate and the Combination of Spinacia Oleracea L. Extract With Prothrombin Complex Concentrate on the Reversal of Apixaban Anticoagulation in a Rabbit Model

Annals of Phytomedicine: An International Journal
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy